These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8579721)

  • 41. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group.
    Kulmala P; Savola K; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Ilonen J; Tuomilehto J; Akerblom HK; Knip M
    Diabetes; 2000 Jan; 49(1):48-58. PubMed ID: 10615949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
    Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
    Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenetic and clinical characterization of slowly progressive IDDM.
    Kobayashi T; Tamemoto K; Nakanishi K; Kato N; Okubo M; Kajio H; Sugimoto T; Murase T; Kosaka K
    Diabetes Care; 1993 May; 16(5):780-8. PubMed ID: 8098691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of pathogenesis of juvenile new-onset diabetes.
    Wang J; Miao D; Wang Y; Lu B; Babu S; Klingensmith G; Rewers M; Eisenbarth GS; Yu L
    J Diabetes; 2011 Jun; 3(2):132-7. PubMed ID: 21138544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenetic determinants and prediction of IDDM in French schoolchildren.
    Lévy-Marchal C; Dubois F; Noël M; Tichet J; Czernichow P
    Diabetes; 1995 Sep; 44(9):1029-32. PubMed ID: 7657024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
    Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
    Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes.
    DeAizpurua HJ; Honeyman MC; Harrison LC
    J Autoimmun; 1992 Dec; 5(6):759-70. PubMed ID: 1489487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
    Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
    Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prevalence of type 1 diabetes-specific autoantibodies and of certain HLA patterns in celiac disease].
    Schilling I; Conrad K; Füssel M; Henker J
    Dtsch Med Wochenschr; 2003 Jan; 128(5):185-9. PubMed ID: 12557109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus.
    Serjeantson SW; Kohonen-Corish MR; Rowley MJ; Mackay IR; Knowles W; Zimmet P
    Diabetologia; 1992 Oct; 35(10):996-1001. PubMed ID: 1360432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune reactivity of diabetes-associated human monoclonal autoantibodies defines multiple epitopes and detects two domain boundaries in glutamate decarboxylase.
    Syren K; Lindsay L; Stoehrer B; Jury K; Lühder F; Baekkeskov S; Richter W
    J Immunol; 1996 Dec; 157(11):5208-14. PubMed ID: 8943434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.
    Korhonen S; Knip MM; Kulmala P; Savola K; Akerblom HK; Knip M;
    Diabetes Metab Res Rev; 2002; 18(1):43-8. PubMed ID: 11921417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Islet cell antibodies: variable immunostaining of pancreatic islet cells and carcinoid tissue.
    Hallberg A; Juhlin C; Berne C; Kämpe O; Karlsson FA
    J Intern Med; 1995 Sep; 238(3):207-13. PubMed ID: 7673849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.